Di Maio Massimo, Perrone Francesco
Clinical Trials Unit, National Cancer Institute, 80131 Naples, Italy.
Health Qual Life Outcomes. 2003 Sep 17;1:44. doi: 10.1186/1477-7525-1-44.
The incidence of most types of cancers is age-dependent and the progressive ageing is rapidly increasing the number of elderly people who need treatment for cancer. Elderly patients present peculiar characteristics that make the choice of the correct treatment more difficult and these patients are often undertreated. Moreover, elderly patients are largely underrepresented in cancer treatment trials, and this makes the experimental evidence on this topic even weaker. Health-related Quality of Life (QOL) has been considered as one of the hard end-points for clinical cancer research, and treatment of elderly cancer patients represents a typical situation where its assessment can be particularly useful, because the expected toxicity of treatment could be relevant in the discussion of the treatment choice. However, QOL assessment in the elderly is complicated by several unresolved methodological problems (higher frequency of illiteracy, worse compliance with the questionnaires, concomitant diseases, use of instruments not validated in the aged population). Conduct of clinical trials dedicated to elderly patients is now encouraged but there are few published studies. Advanced non-small-cell lung cancer is one of the fields with the largest amount of research on QOL in elderly patients. The ELVIS study demonstrated the efficacy of single-agent chemotherapy, both in terms of QOL and of survival. The MILES study, in which combination chemotherapy was not superior than single agents, showed that baseline QOL is a strong prognostic indicator in these patients. QOL of patients with breast cancer has been another important field in clinical research over the last decades, and interest on this topic in elderly patients is growing, from loco-regional to palliative treatment. In conclusion, some steps have been done in clinical cancer research dedicated to elderly patients, and the role of QOL assessment in this setting is important. However, many methodological problems must be resolved, in order to obtain reliable and useful results. A QOL assessment could also be useful for elderly patients in clinical practice, where it could improve patient-clinician communication: a wider application of properly selected instruments should be recommended.
大多数类型癌症的发病率与年龄相关,而人口的逐渐老龄化正在迅速增加需要接受癌症治疗的老年人数量。老年患者具有一些特殊特征,这使得选择正确的治疗方法更加困难,而且这些患者常常得不到充分治疗。此外,老年患者在癌症治疗试验中的代表性严重不足,这使得关于该主题的实验证据更加薄弱。健康相关生活质量(QOL)一直被视为临床癌症研究的重要终点之一,而老年癌症患者的治疗是评估QOL特别有用的典型情况,因为治疗的预期毒性在治疗选择的讨论中可能具有重要意义。然而,老年人的QOL评估因一些未解决的方法学问题而变得复杂(文盲率较高、对问卷的依从性较差、合并症、使用未在老年人群中验证的工具)。现在鼓励开展针对老年患者的临床试验,但已发表的研究很少。晚期非小细胞肺癌是老年患者QOL研究最多的领域之一。ELVIS研究证明了单药化疗在QOL和生存方面的疗效。MILES研究中联合化疗并不优于单药化疗,该研究表明基线QOL是这些患者的一个强有力的预后指标。在过去几十年中,乳腺癌患者的QOL一直是临床研究的另一个重要领域,并且在老年患者中,从局部区域治疗到姑息治疗,对该主题的关注正在增加。总之,在针对老年患者的临床癌症研究中已经取得了一些进展,QOL评估在这种情况下的作用很重要。然而,必须解决许多方法学问题,以获得可靠和有用的结果。QOL评估在临床实践中对老年患者也可能有用,它可以改善医患沟通:应该推荐更广泛地应用适当选择的工具。